By Staff Reporter
The Medicines Control Authority of Zimbabwe (MCAZ) has announced a Class II recall of a batch of YAZ Plus contraceptive tablets due to a quality defect that could compromise their efficacy and pose risks to patients.
The recall affects YAZ PLUS TABLETS, REG. NO.: 2022/21.2.1/6235, BATCH: WEW961J, manufactured by Bayer (Pty) Ltd. South Africa. According to MCAZ, the defective packs contain an incorrect configuration of tablets: 24 light orange hormone-free tablets and 4 pink hormone tablets, instead of the required 24 pink hormone tablets and 4 light orange hormone-free tablets.
This deviation from product quality specifications may result in reduced efficacy and potential harm to patients, which is why we have taken this precautionary measure to safeguard public health,” said Richard Rukwata, MCAZ Director.
The authority has instructed all licensed wholesalers, pharmacies, public and private clinics, and hospitals to immediately quarantine any affected units of the batch. MCAZ is working closely with Bayer (Pty) Ltd and the local distributors in Zimbabwe to ensure a smooth recall process.
Public Advisory
Members of the public using YAZ Plus contraceptives are urged to check the batch number on their packs. If their tablets are from the affected batch (WEW961J), they should immediately stop using them, return the packs to their pharmacist, and consult a healthcare professional for further guidance.
“We encourage patients to act swiftly if they have the defective batch and seek professional advice. The safety of consumers is our top priority,” Rukwata added.
The recall highlights the importance of stringent quality control in pharmaceutical products to ensure patient safety and trust.
